FIERRO, Maria Teresa
 Distribuzione geografica
Continente #
NA - Nord America 8243
EU - Europa 7140
AS - Asia 2957
SA - Sud America 150
OC - Oceania 82
AF - Africa 68
Continente sconosciuto - Info sul continente non disponibili 37
Totale 18677
Nazione #
US - Stati Uniti d'America 8015
CN - Cina 1704
IT - Italia 1661
IE - Irlanda 877
DE - Germania 692
FR - Francia 692
SE - Svezia 640
KR - Corea 550
UA - Ucraina 503
FI - Finlandia 439
GB - Regno Unito 392
AT - Austria 291
JP - Giappone 245
ES - Italia 208
PL - Polonia 207
CA - Canada 195
IN - India 118
VN - Vietnam 113
DK - Danimarca 82
CH - Svizzera 79
NL - Olanda 75
AU - Australia 70
BR - Brasile 65
BE - Belgio 57
TR - Turchia 51
SN - Senegal 46
GR - Grecia 45
EU - Europa 37
RO - Romania 34
HK - Hong Kong 32
RU - Federazione Russa 32
NO - Norvegia 30
MX - Messico 27
AR - Argentina 24
CO - Colombia 24
IL - Israele 24
PT - Portogallo 24
TW - Taiwan 23
CL - Cile 19
CZ - Repubblica Ceca 19
HU - Ungheria 15
NZ - Nuova Zelanda 12
SA - Arabia Saudita 12
PE - Perù 11
SG - Singapore 11
TH - Thailandia 11
MY - Malesia 10
SI - Slovenia 9
EG - Egitto 8
PH - Filippine 8
IR - Iran 7
SK - Slovacchia (Repubblica Slovacca) 7
EC - Ecuador 6
ID - Indonesia 6
UZ - Uzbekistan 6
AL - Albania 5
BY - Bielorussia 4
HR - Croazia 4
JO - Giordania 4
KW - Kuwait 4
PK - Pakistan 4
ZA - Sudafrica 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
HN - Honduras 3
MK - Macedonia 3
QA - Qatar 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
EE - Estonia 2
IQ - Iraq 2
MA - Marocco 2
MU - Mauritius 2
NG - Nigeria 2
PA - Panama 2
AM - Armenia 1
BO - Bolivia 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MT - Malta 1
NP - Nepal 1
SM - San Marino 1
TN - Tunisia 1
TZ - Tanzania 1
Totale 18677
Città #
Chandler 1490
Beijing 1186
Dublin 872
Houston 419
Fairfield 408
Jacksonville 379
Princeton 363
Villeurbanne 360
Medford 344
Torino 330
Ann Arbor 308
Wilmington 272
Redwood City 257
Vienna 242
Ashburn 210
Dearborn 209
Woodbridge 203
Nyköping 191
Warsaw 183
Cambridge 164
Seattle 151
Milan 133
Boston 113
Pisa 102
Dong Ket 70
Tokyo 68
Boardman 66
Toronto 63
Duncan 53
Fremont 51
Norwalk 46
Shanghai 46
Guangzhou 42
Hebei 42
Verona 41
Brussels 40
Nanjing 40
Hangzhou 38
New York 38
Hefei 33
Madrid 30
San Diego 29
Falls Church 28
Berlin 27
Bologna 27
Ottawa 27
Rome 27
Paris 26
Philadelphia 26
Seoul 26
Mountain View 25
Rochester 25
Shenyang 24
Turin 24
Athens 23
Chengdu 23
London 22
Napoli 22
Kunming 20
Lachine 20
Barcelona 19
Jinan 19
Leiden 19
São Paulo 19
Chicago 18
Helsinki 18
Munich 18
Zhengzhou 18
Istanbul 17
San Mateo 17
Taipei 17
Mumbai 16
Phoenix 16
Silver Spring 16
Tianjin 15
Pavia 14
Saluzzo 14
Nanchang 13
Redmond 13
Central District 12
Florence 12
Bogotá 11
Brescia 11
Hazelwood 11
Muenster 11
Palermo 11
Wuhan 11
Baltimore 10
Baotou 10
Dallas 10
Fuzhou 10
Los Angeles 10
Pittsburgh 10
San Francisco 10
Sydney 10
Vancouver 10
Andover 9
Bucharest 9
Durham 9
Düsseldorf 9
Totale 10699
Nome #
Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial 2420
Prognostic role of Histologic regression in primary cutaneous melanoma: A Systematic Review and Meta-analysis 426
Blood Flow Cytometry in Sézary Syndrome: New Insights on Prognostic Relevance and Immunophenotypic Changes During Follow-up. 396
Vitiligo is an independent favourable prognostic factor in stage III and IV metastatic melanoma patients: results from a single-institution hospital-based observational cohort study 284
Intestinal involvement in toxic epidermal necrolysis. A case report and review of literature. 254
Spiky follicular mycosis fungoides: a clinicopathologic study of 8 cases. 254
Metastasi ossee da melanoma: incidenza e impatto sulla sopravvivenza 238
Risk factors related to late metastases in 1,372 melanoma patients disease free more than 10 years. 230
Atopic dermatitis in a phenylketonuric untreated patient 226
Genetic mutations in primary malignant melanoma of the esophagus: case report and literature review 224
Clinicopathologic spectrum of cutaneous diseases in patients with hematologic malignancies with or without allogeneic bone marrow transplantation: an observational cohort study in 101 patients. 223
Melanoma of the lower extremities: foot site is an independent risk factor for clinical outcome 216
Giornale italiano di Dermatologia e Venereologia 202
Functional and Phenotypical Impairment of Polymorphonuclear Cells in Atopic Dermatitis: An Additional Cause for the Known Susceptibility to Infections? [*M.T. Fierro and G. Banche contributed equally to this work] 192
Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role? 191
Phenotypical characterization of circulating cell subsets in pyoderma gangrenosum patients: the experience of the Italian immuno-pathology group 181
HPyV6, HPyV7 and TSPyV DNA sequences detection in skin disease patients and healthy subjects. 180
Functional and phenotypical alterations of polymorphonuclear cells in Sézary syndrome patients [*MT. Fierro and AMC Cuffini contributed equally to this work] 177
Malattia di Castleman multicentrica associata a sarcoma di Kaposi Savoia P, Fierro MT, Quaglino P, Zaccagna A, Bernengo MG 164
Human Endogenous Retrovirus Expression in Primary Cutaneous T-Cell Lymphomas 163
Alterazioni funzionali e fenotipiche dei polimorfonucleati nella sindrome di sezary 159
Reciprocal modulation of circulating CD4+CD25+bright T cells induced by extracorporeal photochemotherapy in cutaneous T-cell lymphoma and chronic graft-versus-host-disease patients. 154
High-dose immunoglobulines and extracorporeal photochemotherapy in the treatment of febrile ulceronecrotic Mucha-Habermann disease. 151
BRAF and MEK inhibitors increase PD1-positive melanoma cells leading to a potential lymphocyte-independent synergism with anti-PD1 antibody 144
Long-term evolution of an untreated primary cutaneous follicle center lymphoma of the scalp 135
Synergy of molecular targeted approaches and immunotherapy in melanoma: preclinical basis and clinical perspectives 135
Metastatic sebaceous cell carcinoma, review of the literature and use of electrochemotherapy as possible new treatment modality 125
Rischio di recidiva ed intervallo libero da malattia: linee guida di terapia e follow-up. 123
Epstein-Barr virus in cutaneous T-cell lymphomas: evaluation of the viral presence and significance in skin and peripheral blood 111
Prognostic differences across sexes in melanoma patients: What has changed from the past? 110
The infliximab biosimilar in the treatment of moderate to severe plaque psoriasis. 107
A novel leukemia T-cell line (PF-382) with phenotypic and functional features of suppressor lymphocytes. 104
Studio citofluorimetrico della popolazione circolante CD4+CD27+ nelle eritrodermie infiammatorie e nei linfomi cutanei: relazione con i livelli di cellule CD4+CD26- ed utilità diagnostica. 103
Association of Histologic Regression in Primary Melanoma With Sentinel Lymph Node Status: A Systematic Review and Meta-analysis 101
miR-155 expression in Primary Cutaneous T-Cell Lymphomas (CTCL) 99
Fotoferesi: applicazioni terapeutiche “off-label” 98
Alterazioni funzionali e fenotipiche dei polimorfonucleati nei pazienti affetti da dermatite atopica 97
TERT Promoter Mutations are Associated with Visceral Spreading in Melanoma of the Trunk 94
Alemtuzumab for the treatment of Sézary sindrome: clinical and immunological findings in 10 patients. 88
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markers. 86
Interleuchina-2 e Interferone-gamma nella leucemia linfatica cronica a cellule B 85
Associazione di etoposide, idarubicina, ciclofosfamide, vincristina, prednisone e bleomicina (VICOP-B) nel trattamento dei linfomi cutanei 84
Prognostic relevance of baseline and sequential peripheral blood tyrosinase expression in 200 consecutive advanced metastatic melanoma patients. 83
Safety and efficacy of nivolumab in patients with rare melanoma subtypes who progressed on or after ipilimumab treatment: a single-arm, open-label, phase II study (CheckMate 172) 80
Interleukin 2 does not promote the in vitro and in vivo proliferation and growth of human acute leukaemia cells of myeloid and lymphoid origin. 79
Immunoregulatory T-cell defects in B-cell chronic lymphocytic leukemia: cause or consequence of the disease? The contributory role of decreased availability of interleukin 2 (IL-2). 79
Interleukin 2 (IL 2) and interferon-gamma production by T lymphocytes from patients with B-chronic lymphocytic leukemia: evidence that normally released IL 2 is absorbed by the neoplastic B cell population. 78
Human herpesvirus 7 detection by quantitative real time polymerase chain reaction in primary cutaneous T-cell lymphomas and healthy subjects: lack of a pathogenic role 77
Fluorescence-Advanced-Videodermatoscopy (FAV): a new method for in-vivo skin evaluation 77
Genotypic characterization of common acute lymphoblastic leukemia may improve the phenotypic classification. 76
Low-dose intermittent alemtuzumab in the treatment of Sézary syndrome: clinical and immunologic findings in 14 patients. 76
'Aleukemic' granulomatous leukemia cutis. 74
Immature T lymphocytes in human cord blood identified by monoclonal antibodies: a model for the study of the differentiation pathway of T cells in humans. 73
Normal helper T-cell function in hairy-cell leukaemia. 73
Chronic T-cell leukaemias. A variant of T-prolymphocytic leukaemias: morphological, immunological and clinical characterization of 2 cases 71
[Effect of human plasma on the in vitro formation of T-lymphocyte colonies] 71
Virus di Epstein-Barr e linfomi primitivi cutanei: valutazione della carica virale mediante PCR quantitativa-competitiva (QC-PCR) su biopsia. 70
Treatment of metastatic melanoma: a multidisciplinary approach 70
Chronic T-cell leukaemias. III. T-colonies, PHA response and correlation with membrane phenotype. 69
Prognostic factors in primary cutaneous B-cell lymphoma: the Italian Study Group for Cutaneous Lymphomas. 69
Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: A multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium 69
Associazione di ciclofosfamide, vincristina e prednisone (COP) nel trattamento dei linfomi cutanei: 20 anni di follow-up. 68
Un caso di leucemia/linfoma a cellule T dell'adulto con localizzazioni cutanee: caratteristiche cliniche, istologiche ed immunologiche 68
Evaluation of PMNs functional and phenotypical alterations in mycosis fungoides patients. 68
Flow-cytometry and functional evaluation of the CD39/CD73 adenosinergic immunosuppressive axis in patients with Sézary syndrome 68
Low-dose intermittent Alemtuzumab in Sézary Syndrome: clinical activity, toxicity profile and immunological findings in 17 patients. 65
Macrophage-mediated immunostimulation modulates therapeutic efficacy of interleukin-2 based chemoimmunotherapy in advanced metastatic melanoma patients. 65
Abstract 5603: Melanoma PD1 expression is upregulated by MAPK inhibitors leading to an immune-independent synergism with anti-PD1 antibodies 65
Clonal heterogeneity in mycosis fungoides/Sézary Syndrome: incidence, relation with clinico-pathologic features and prognostic significance 64
Le infezioni nella micosi fungoide e nella sindrome di Sézary 63
1975-2011 Overall Survival, Disease Free Survival and Survival after Recurrence across gender in melanoma patients: what has changed? 63
Different stages of B cell differentiation in non-T acute lymphoblastic leukemia 63
Arrhythmias in metastatic melanoma patient treated with targeted therapy and ICD implant. 62
B-chronic lymphocytic leukaemia patients with stable benign disease show a distinctive membrane phenotype. 62
BRAFi/MEKi in patients with metastatic melanoma: Predictive factors of complete response 62
Electrochemotherapy in treatment of skin melanoma metastases 62
TCRgamma-Chain Gene Rearrangement by PCR-Based GeneScan: Diagnostic Accuracy Improvement and Clonal Heterogeneity Analysis in Multiple Cutaneous T-Cell Lymphoma Samples 61
Clinical and prognostic reports from 270 patients with multiple primary melanomas: a 34-year single-institution study 61
Prognostic factors in Sézary syndrome: a multivariate analysis of clinical, haematological and immunological features. 60
CD26 expression on keratinocytes in normal skin, inflammatory skin diseases and cutaneous T-cell lymphomas (CTCL). 59
The relevance of the CD4+ CD26- subset in the identification of circulating Sézary cells. 59
Time course and pattern of first relapse in stage I-II primary cutaneous melanoma: a multivariate analysis of disease-free survival in 3,174 patients followed-up at the Turin Melanoma Centre from 1975 to 2004 58
TCRgamma-chain gene rearrangement by GeneScan: incidence and significance of clonal heterogeneity in Sézary syndrome. 58
Autoimmune connective tissue diseases and pregnancy 58
CD26 (DPP-IV)- A useful marker in Sezary sindrome 58
Multivariate analysis of prognostic factors in 58 Sézary syndrome patients 58
Caratterizzazione immunoistochimica e citofluorimetrica di una nuova linea di melanoma. 58
Multilineage cell involvement in Ph1-negative, bcr-negative chronic myeloid leukemia. 57
Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN). 57
Clinical significance of sequential tyrosinase expression in the peripheral blood of disease-free melanoma patients: a review of literature data 57
CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients. 57
Alemtuzumab nel trattamento dei linfomi cutanei a cellule T in fase avanzata: studio pilota “dose finding”. 57
Pinocchio cells: morphologically atypical immunologically heterogeneous lymphocytes induced by treatment with interleukin 2. 56
Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance 56
Th1, Th2, Th17 and Treg expression in cutaneous T-cell lymphoma patients: modulation of master gene targets. 56
PCR Real time Mismatch Amplification Mutation Assay (MAMA Real Time PCR) for evaluation of TNFα promoter gene polymorphism -308 G/A in patients with psoriasis. 56
Quantificazione mediante PCR dell’EBV-DNA da biopsie cutanee di pazienti con CTCL (micosi fungoide e sindrome di Sezary) 56
Bullous, cutaneous, pleomorphic T-cell Lymphoma: analysis of integrins and extracellular matrix components. 56
Metastatic melanoma of the heart. 56
Autocrine or paracrine models of cytokine production and utilization in B-cell chronic lymphocytic leukaemia 56
Totale 13097
Categoria #
all - tutte 30689
article - articoli 0
book - libri 0
conference - conferenze 7455
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38144


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20182281 0000 00 0487 11324709399
2018/20191800 8710216573 83122 103234 89196364182
2019/20203130 142115156288 224409 385272 347296264232
2020/20212547 326157181157 231205 183129 263248208259
2021/20223345 165135182194 279157 224226 183220618762
2022/20233685 586391170429 4991128 4811 0000
Totale 19525